Enzon to Review Asset Sales, Sale of the Company

Enzon to Review Asset Sales, Sale of the Company

[at noodls] – PISCATAWAY, NJ — (Marketwire) — 12/17/12 — Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has retained Lazard to act as financial advisor in a review of the possible … more

View todays social media effects on ENZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Enzon is hiring next, click here to view

Share this post